The Inhaled Drug Testing Equipment is designed to test the unit release dose uniformity (DDCU) of inhalant aerosols, powders, sprays, and liquid formulations in or between tanks at the beginning, middle, and end of use.
The Inhaled Drug Testing Equipment is designed to test the unit release dose uniformity (DDCU) of inhalant aerosols, powders, sprays, and liquid formulations in or between tanks at the beginning, middle, and end of use. At the same time, the new generation of medical impactors meets the requirements of the United States Pharmacopoeia instrument, the European Pharmacopoeia instrument, and the Chinese Pharmacopoeia (2020 edition) in the determination of fine particle aerodynamic characteristics of inhalation preparations.
Meet the Standards
Chinese Pharmacopoeia (2020 edition) No. 4 (0111, inhaled preparations)
Chinese Pharmacopoeia (2020 edition) Part IV (0951, Determination of Fine Particle Aerodynamic Characteristics of inhalation preparations)
YY/T 1743-2021 Anesthesia and respiratory equipment atomization systems and components
Product Features
1. Meet the requirements of US pharmacopeia instruments, European pharmacopeia instruments, and Chinese pharmacopeia instruments;
2. Variable frequency vacuum pump imported from Germany, flow 0 ~ 100L/min variable frequency adjustable;
3. High-precision electronic flowmeter, accurate measurement of pumping flow;
4. High-precision differential pressure sensor accurately measures the pressure difference before and after the suction device;
5. The new generation of the pharmaceutical impactor (NGI) consists of 7 layers of the impactor and a (MOC) micropore collector;